Skip to content

Surveillance of protein and phosphorus intake in patients with chronic kidney disease and exploration of related evaluation methods: a multicentre, cross-sectional study

Surveillance of protein and phosphorus intake in patients with chronic kidney disease and exploration of related evaluation methods in china

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCS-14004462
Enrollment
Unknown
Registered
2014-04-01
Start date
2014-04-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

:nutritional education

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with CKD (stage 3?5) (eGFR=60ml/min/1.73m2) including patients on hemodialysis and peritoneal dialysis (stage 5D); 2.patients with capability to read and write;3.patients have received the standard CKD management according to the guideline at least 3 months;4.patients with stable clinical status;5.Age: 18-75 years;6.Patients with normal diet through the mouth;7.Patients with informed consent form signed.

Exclusion criteria

Exclusion criteria: 1.Patients after renal transplantation; 2.Patients with diabetes; 3.Patients with urine protein>3g/24h; 4.Patients with 18.5kg/m2>BMI>28 kg/m2; 5.Patients with the severity of edema higher than tree-degree; 6.Patients with serious liver dysfunction (ALT and AST above the normal upper limit by 2.5 times) and patients with cirrhosis; 7.Patients with serious cardiac dysfunction (NYHA grade III/IV); 8.Patients with Serious blood disease history (coagulation disorders or multiple myeloma); 9.Patients combined with malignant tumors; 10.Patients combined with Hyperthyroidism, hypothyroidism and Cushing's syndrome among other diseases which seriously influence nutrition metabolism; 11.Patient's urine volume <400ml/d before dialysis; 12.Patients with active bacterial or viral infection; 13.Patients already included in other clinical trials; 14.patients with an indication for enteral and parenteral nutrition; 15.Other patients who are considered not suitable to participate this study by investigators.

Design outcomes

Secondary

MeasureTime frame
24h urine test;Biochemical variables;

Primary

MeasureTime frame
Height;weight;Blood Pressure;Blood routine examination;

Countries

China

Contacts

Public ContactChen Wei

Peking Union Medical College Hospital

txchenwei@sina.com+86 13911006820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026